Fibrinolytic Therapy Versus Medical Thoracoscopy

Status Completed

Clinical Trial Summary

The purpose of this prospective randomized clinical trial is to compare two currently accepted standard-of-care treatment strategies: medical thoracoscopy as compared to instillation of intrapleural tissue plasminogen activator (TPA) and human recombinant deoxyribonuclease (DNase) for the management of complicated pleural infections in adults as defined as complicated parapneumonic effusions or pleural empyema.

Clinical Trial Description

Pleural infection (empyema or complex parapneumonic effusion [CPPE]) represents one of the common clinical diagnoses encountered in clinical practice in the United States (US) and worldwide. The incidence of pleural infection continues to rise with an annual incidence of approximately 65,000 in the US and United Kingdom (UK). It is associated with substantial morbidity and mortality as well as increased hospital costs despite advances in medical diagnostic and therapeutic strategies. The overall mortality of pleural infection approaches 20% and it is above 30% in elderly patients over 65 years and immunocompromised patients. Treatment of CPPE or empyema requires antibiotics and drainage of the pleural cavity.3 However, in about 30% of cases, it is difficult to remove the fluid due to loculations, septations and increased viscosity of the pleural fluid, and around 20% will need surgical intervention to adequately treat the pleural infection. Specific Aim 1: To compare the efficacy of early medical thoracoscopy versus fibrinolytic therapy (tPA/DNase) in patients with complicated parapneumonic effusions or pleural empyema. CPPE is defined as non-purulent effusion in a patient with clinical evidence of infection such as fever and/or elevated blood leukocyte count and/or elevated CRP, with pleural fluid pH ≤ 7.2 (measured by blood-gas analyzer), or pleural fluid glucose < 60 mg/dl or pleural fluid LDH >1000 IU/L26. Empyema is defined as pus within the pleural space and/or presence of bacteria on pleural fluid Gram stain or culture. For patients to be considered for the trial they need to fulfill one of the following criteria: 1) CPPE along with evidence of septated pleural effusion on pleural ultrasonography and/or chest CT scan or 2) empyema. ;

Study Design

Related Conditions & MeSH terms

Pleural Diseases

Clinical Trial Details

NCT number	NCT03213834
Study type	Interventional
Source	University of Florida
Contact
Status	Completed
Phase	Phase 4
Start date	September 14, 2017
Completion date	February 4, 2020

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02891642` - Liquid Biopsy With Immunomagnetic Beads Capture Technique for Malignant Cell Detection in Body Fluid
Recruiting	`NCT05910112` - Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Completed	`NCT04538235` - Analgesic Non Inferiority of the Thoracic Bi-block in Comparison With Thoracic Epidural for VATS.
Completed	`NCT01475084` - Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study	Phase 2/Phase 3
Completed	`NCT03468933` - Fibrinolysis Compared to Thoracoscopy for Pleural Infection	Phase 4
Recruiting	`NCT03973957` - Talc Outpatient Pleurodesis With Indwelling Catheter	N/A
Completed	`NCT03922841` - Pleural Disease: Phenotypes, Diagnostic Yield and Outcomes
Not yet recruiting	`NCT03172585` - Transthoracic Sonography Versus High Resolution Computed Tomography in Alveolar Intersitial Syndrome	N/A
Completed	`NCT02973139` - Fibrinolysis Compared to Thoracoscopy for Pleural Infection	N/A
Completed	`NCT03997669` - The Diagnosis and Mechanism of Pleural Effusion
Completed	`NCT02359383` - Impact of Respiratory Physiotherapy in the Management of Infectious Pleural Effusion	N/A
Completed	`NCT01366261` - Rigid Versus Semirigid Thoracoscopy in Diagnosing Pleural Diseases: a Randomized Study	Phase 3
Completed	`NCT00720954` - Rigid Thoracoscopy Versus CT-Guided Pleural Needle Biopsy	N/A
Completed	`NCT01193439` - Safety of Thoracoscopy in Patients With High Risk	N/A
Recruiting	`NCT04193241` - Suturing With U-Technique Versus Un-Reapproximated Wound Edges During Removal of Closed Thoracostomy Tube Drain	N/A
Recruiting	`NCT06226909` - The Efficacy of Shear-wave Elastography-guided Biopsy for Diagnosis in Pleural Disease	N/A
Recruiting	`NCT06180603` - Strategy for Prompt and Effective Thoracentesis in the Emergency Department	N/A
Active, not recruiting	`NCT05077111` - A Comparative Study Between Regional Anesthesia in Thoracoscopes and the Conventional General Anesthesia	Phase 4
Completed	`NCT05906823` - Analysis of Metabonomics for Pleural Effusion
Completed	`NCT01472172` - Pleural Cryobiopsies During Semirigid Thoracoscopy: A New Technique	Phase 0

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.